Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2024

M-TEER in SMR: Device Selection, Procedural Considerations, and How to Define Success

Presenter: Saibal Kar

October 29, 2024

Presentation TCT 2024

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

Presenter: Gregg Stone

October 29, 2024

Presentation TCT 2024

What Every Cardiologist Should Know About the Management of Heart Failure

Presenter: James Udelson

October 29, 2024

Presentation TCT 2024

How To Select the Most Appropriate SMR Patients For M-TEER?

Presenter: JoAnn Lindenfeld

October 29, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Advertisement

M-TEER in SMR: Device Selection, Procedural Considerations, and How to Define Success

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

What Every Cardiologist Should Know About the Management of Heart Failure

How To Select the Most Appropriate SMR Patients For M-TEER?

CON: TMVR Has too Many Problems – Just Do M-TEER

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content